MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) stock is trading higher on Monday after the company released new preclinical ...

Promising Preclinical Results Position Ketamir-2 as a Potential Breakthrough Therapy That Surpasses Current Treatments, With Results to Be ...

Manur Multi Specialty Hospital successfully treats 14-year-old boy with Guillain-Barre Syndrome, AMSAN, and breathing issues.

The treatment was extensive a stem-cell transplant, immunotherapy, an operation to remove the tumour and chemotherapy. After ...